NXONE Trademark

Trademark Overview


On Friday, October 21, 2022, a trademark application was filed for NXONE with the United States Patent and Trademark Office. The USPTO has given the NXONE trademark a serial number of 79358449. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by BIP FOCUS GLOBAL Co., Ltd.. The NXONE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparation for skin care; tissue-regenerative pharmaceutical preparations for the treatment of damaged skin and tissue; pre-filled syringes sold containing hyaluronic acid for medical purposes; pre-filled syringes sold containing polylactic acid for medical purposes; pre-filled syringes sold containing poly-L-lactic acid for medical purposes; pre-filled syringes sold containing polydioxanone for medical purposes; pre-filled syringes sold containing polynucleotide for medical purposes; pre-filled syringes sold containing polydeoxyribonucleotide for medical purposes; medicines for human purposes, namely, medicinal cream for skin care; pharmaceutical preparations for wounds; injectable dermal fillers; gels, creams and solutions for dermatological use; pharmaceutical preparations for treating skin wounds by activating cellular function

Body insertion thread for medical use; medical apparatus, namely, artificial breast implants in gel form; thread for medical use; medical apparatus for injecting fillers; lifting thread for medical purposes; medical apparatus and instruments for plastic surgery; needles for medical purposes; endoprostheses
nxone

General Information


Serial Number79358449
Word MarkNXONE
Filing DateFriday, October 21, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7394021
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparation for skin care; tissue-regenerative pharmaceutical preparations for the treatment of damaged skin and tissue; pre-filled syringes sold containing hyaluronic acid for medical purposes; pre-filled syringes sold containing polylactic acid for medical purposes; pre-filled syringes sold containing poly-L-lactic acid for medical purposes; pre-filled syringes sold containing polydioxanone for medical purposes; pre-filled syringes sold containing polynucleotide for medical purposes; pre-filled syringes sold containing polydeoxyribonucleotide for medical purposes; medicines for human purposes, namely, medicinal cream for skin care; pharmaceutical preparations for wounds; injectable dermal fillers; gels, creams and solutions for dermatological use; pharmaceutical preparations for treating skin wounds by activating cellular function
Goods and ServicesBody insertion thread for medical use; medical apparatus, namely, artificial breast implants in gel form; thread for medical use; medical apparatus for injecting fillers; lifting thread for medical purposes; medical apparatus and instruments for plastic surgery; needles for medical purposes; endoprostheses

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIP FOCUS GLOBAL Co., Ltd.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressKR

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressKR

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressKR

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressKR

Trademark Events


Event DateEvent Description
Friday, December 23, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 31, 2022APPLICATION FILING RECEIPT MAILED
Monday, August 7, 2023ASSIGNED TO EXAMINER
Monday, August 7, 2023NON-FINAL ACTION WRITTEN
Monday, August 7, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 30, 2023REFUSAL PROCESSED BY MPU
Wednesday, August 30, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 18, 2023REFUSAL PROCESSED BY IB
Thursday, February 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 21, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024NOTIFICATION PROCESSED BY IB
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, June 8, 2024CHANGE OF OWNER RECEIVED FROM IB